200 related articles for article (PubMed ID: 34455585)
41. t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.
Ehrentraut S; Nagel S; Scherr ME; Schneider B; Quentmeier H; Geffers R; Kaufmann M; Meyer C; Prochorec-Sobieszek M; Ketterling RP; Knudson RA; Feldman AL; Kadin ME; Drexler HG; MacLeod RA
PLoS One; 2013; 8(1):e53767. PubMed ID: 23372669
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous T-cell lymphoma: molecular and cytogenetic findings.
Sterry W
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):13-7. PubMed ID: 17474354
[TBL] [Abstract][Full Text] [Related]
43. p38γ activation triggers dynamical changes in allosteric docking sites.
Rodriguez Limardo RG; Ferreiro DN; Roitberg AE; Marti MA; Turjanski AG
Biochemistry; 2011 Mar; 50(8):1384-95. PubMed ID: 21235211
[TBL] [Abstract][Full Text] [Related]
44. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms.
Kwong J; Hong L; Liao R; Deng Q; Han J; Sun P
J Biol Chem; 2009 Apr; 284(17):11237-46. PubMed ID: 19251701
[TBL] [Abstract][Full Text] [Related]
45. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
46. Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.
Kodigepalli KM; Li M; Liu SL; Wu L
Cell Cycle; 2017 Jan; 16(2):179-188. PubMed ID: 27929746
[TBL] [Abstract][Full Text] [Related]
47. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
[TBL] [Abstract][Full Text] [Related]
48. Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons.
Qi X; Hou S; Lepp A; Li R; Basir Z; Lou Z; Chen G
J Biol Chem; 2011 Oct; 286(41):35883-35890. PubMed ID: 21878638
[TBL] [Abstract][Full Text] [Related]
49. Systemic chemotherapy promotes HIF-1α-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma.
Wang B; Li K; Wang H; Shen X; Zheng J
Exp Dermatol; 2020 Oct; 29(10):987-992. PubMed ID: 32573814
[TBL] [Abstract][Full Text] [Related]
50. Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.
Faraone D; Aguzzi MS; Toietta G; Facchiano AM; Facchiano F; Magenta A; Martelli F; Truffa S; Cesareo E; Ribatti D; Capogrossi MC; Facchiano A
Neoplasia; 2009 Aug; 11(8):732-42. PubMed ID: 19649203
[TBL] [Abstract][Full Text] [Related]
51. p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
Qi X; Yin N; Ma S; Lepp A; Tang J; Jing W; Johnson B; Dwinell MB; Chitambar CR; Chen G
Stem Cells; 2015 Sep; 33(9):2738-47. PubMed ID: 26077647
[TBL] [Abstract][Full Text] [Related]
52. Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38γ.
Maisonneuve P; Caillet-Saguy C; Vaney MC; Bibi-Zainab E; Sawyer K; Raynal B; Haouz A; Delepierre M; Lafon M; Cordier F; Wolff N
J Biol Chem; 2016 Aug; 291(32):16699-708. PubMed ID: 27246854
[TBL] [Abstract][Full Text] [Related]
53. c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death.
Wu J; Salva KA; Wood GS
J Invest Dermatol; 2015 Mar; 135(3):861-868. PubMed ID: 25140833
[TBL] [Abstract][Full Text] [Related]
54. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
56. p38γ MAPK is required for inflammation-associated colon tumorigenesis.
Yin N; Qi X; Tsai S; Lu Y; Basir Z; Oshima K; Thomas JP; Myers CR; Stoner G; Chen G
Oncogene; 2016 Feb; 35(8):1039-48. PubMed ID: 25961922
[TBL] [Abstract][Full Text] [Related]
57. Reversible resistance to apoptosis in cutaneous T cell lymphoma.
Meech SJ; Edelson R; Walsh P; Norris DA; Duke RC
Ann N Y Acad Sci; 2001 Sep; 941():46-58. PubMed ID: 11594582
[TBL] [Abstract][Full Text] [Related]
58. Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Akamata K; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2012 Jul; 304(5):401-6. PubMed ID: 22526325
[TBL] [Abstract][Full Text] [Related]
59. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.
Hou SW; Zhi HY; Pohl N; Loesch M; Qi XM; Li RS; Basir Z; Chen G
Cancer Res; 2010 Apr; 70(7):2901-10. PubMed ID: 20332238
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.
Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J
J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
